Screener
Nurix Therapeutics, Inc. NRIX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | May 31,2026 | November 30,2025 |
|---|---|---|
| Cash and cash equivalents | $67,685 | $246,960 |
| Marketable securities | 375,844 | 345,981 |
| Prepaid expenses and other current assets | 12,952 | 13,878 |
| Total current assets | 456,481 | 606,819 |
| Operating lease right-of-use assets | 50,107 | 50,517 |
| Property and equipment, net | 20,007 | 22,490 |
| Restricted cash | 968 | 968 |
| Other assets | 7,977 | 7,341 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s total current assets?
- Nurix Therapeutics, Inc. (NRIX) reported total current assets of $456.48M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s total current assets changed year-over-year?
- Nurix Therapeutics, Inc.'s total current assets decreased by 11.4% year-over-year, from $515.33M to $456.48M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s total current assets has grown at a 15.3% compound annual growth rate (CAGR), from $298.43M to $606.82M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Nurix Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude